human interleukin 3 (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
96
Structured Review
R&D Systems
human interleukin 3
Human Interleukin 3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 260 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+interleukin+3/Recombinant+Human+IL-3+Protein/pm41963354-281-22-26
Average 96 stars, based on 260 article reviews
Human Interleukin 3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 260 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+interleukin+3/Recombinant+Human+IL-3+Protein/pm41963354-281-22-26
Average 96 stars, based on 260 article reviews
human interleukin 3 - by Bioz Stars,
2026-10
96/100 stars
Images
Related Articles
Recombinant:Article Title: Xeno-free Reprogramming of Peripheral Blood Mononuclear Erythroblasts on Laminin 521. Article Snippet: .. Dissolve 10 μg Article Title: Supramolecular assembly of GSK3α as a cellular response to amino acid starvation. Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Chemicals, Peptides, and Recombinant Proteins Asparaginase (pegaspargase) Shire Pharmaceuticals Oncaspar Trypan blue Invitrogen Cat#T10282 Human FLT3 R&D systems Cat#398-FK Human interleukin-7 R&D systems Cat#206-IL-010 Human stem cell factor R&D systems Cat#255-SC Puromycin Thermo Fisher Cat#A1113803 Neomycin Carl Roth Cat #CP11.2 Blasticidin Thermo Fisher Cat#R21001 Polybrene Merck Millipore Cat#TR-1003-G Lipofectamine 2000 Invitrogen Cat#11668030 Dexamethasone Sigma-Aldrich Cat#D4902 Vincristine Selleckchem Cat#S1241 6-Mercaptopurine Abcam Cat#ab142389 Rapamycin Selleckchem Cat#S1039 BRD5648 (Wagner et al., 2018) N/A BRD0705 (Wagner et al., 2018) N/A BRD3731 (Wagner et al., 2018) N/A HSP70 inhibitors B (Kang et al., 2014; Taldone et al., 2014). .. CD34+ progenitors were cultured in RPMI (Thermo Fisher Scientific) supplemented with 20% FBS and Article Title: Preventing Differentiation Towards Primitive Macrophages in Stem Cells With Down Syndrome. Article Snippet: On days 0, 2, and 4 of differentiation, cells were cultured in SF- DIFF medium and further supplemented with the following cytokines and chemicals: day 0: 0.5 mM L- ascorbic acid (Sigma- Aldrich), 0.45 mM monothioglycerol (Fujifilm Wako Chemicals), 5 ng/mL recombinant human bone morphogenic protein- 4 (rhBMP- 4, R&D Systems, Minneapolis, MN, USA), 5 ng/mL recombinant human fibroblast growth factor 2 (rhFGF2, R&D Systems); day 2: 0.5 mM L- ascorbic acid, 0.45 mM monothioglycerol, 2 ng/ mL rhBMP- 4, 5 ng/mL rhFGF2, 5 ng/mL recombinant human vascular endothelial growth factor (rhVEGF, R&D Systems), and 2 ng/mL recombinant human/mouse/rat activin A (rhactivin A, R&D Systems); day 4: 0.5 mM L- ascorbic acid, 0.45 mM monothioglycerol, 25 μg/mL gentamicin (FUJIFILM Wako Pure Chemical Corporation), 5 ng/mL rhVEGF and 100 ng/ mL recombinant human colony stimulating factor 1 (rhCSF- 1, R&D Systems). .. On day 6, the culture medium was switched to StemPro- 34 medium (Thermo Fisher Scientific) containing 0.5 mM L- ascorbic acid, 0.45 mM monothioglycerol, penicillin–streptomycin (1×), 150 μg/mL transferrin from human serum (Roche, Basel, Switzerland), 2.0 mM glutamine, 50 ng/ mL rhCSF- 1, 100 ng/mL recombinant human stem cell factor (rhSCF, Nacalai Tesque), 10 ng/mL Article Title: Concomitant inhibition of the thioredoxin system and nonhomologous DNA repair potently sensitizes Philadelphia‐positive lymphoid leukemia to tyrosine kinase inhibitors Article Snippet: For frozen samples whose viability after thawing was less than 90%, dead cells were discarded through centrifugation in the Lymphoprep (STEMCELL Technologies) gradient. .. Cells were seeded onto a 96‐well U‐bottom plate at 0.5 × 10 6 cells/mL in a final volume of 200 μL of SFEM II medium (Gibco), supplemented with 20% FBS (Gibco), 20 ng/mL Article Title: Preventing Differentiation Towards Primitive Macrophages in Stem Cells With Down Syndrome Article Snippet: On days 0, 2, and 4 of differentiation, cells were cultured in SF‐DIFF medium and further supplemented with the following cytokines and chemicals: day 0: 0.5 mM L‐ascorbic acid (Sigma‐Aldrich), 0.45 mM monothioglycerol (Fujifilm Wako Chemicals), 5 ng/mL recombinant human bone morphogenic protein‐4 (rhBMP‐4, R&D Systems, Minneapolis, MN, USA), 5 ng/mL recombinant human fibroblast growth factor 2 (rhFGF2, R&D Systems); day 2: 0.5 mM L‐ascorbic acid, 0.45 mM monothioglycerol, 2 ng/mL rhBMP‐4, 5 ng/mL rhFGF2, 5 ng/mL recombinant human vascular endothelial growth factor (rhVEGF, R&D Systems), and 2 ng/mL recombinant human/mouse/rat activin A (rhactivin A, R&D Systems); day 4: 0.5 mM L‐ascorbic acid, 0.45 mM monothioglycerol, 25 μg/mL gentamicin (FUJIFILM Wako Pure Chemical Corporation), 5 ng/mL rhVEGF and 100 ng/mL recombinant human colony stimulating factor 1 (rhCSF‐1, R&D Systems). .. On day 6, the culture medium was switched to StemPro‐34 medium (Thermo Fisher Scientific) containing 0.5 mM L‐ascorbic acid, 0.45 mM monothioglycerol, penicillin–streptomycin (1×), 150 μg/mL transferrin from human serum (Roche, Basel, Switzerland), 2.0 mM glutamine, 50 ng/mL rhCSF‐1, 100 ng/mL recombinant human stem cell factor (rhSCF, Nacalai Tesque), 10 ng/mL Cell Culture:Article Title: Supramolecular assembly of GSK3α as a cellular response to amino acid starvation. Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Chemicals, Peptides, and Recombinant Proteins Asparaginase (pegaspargase) Shire Pharmaceuticals Oncaspar Trypan blue Invitrogen Cat#T10282 Human FLT3 R&D systems Cat#398-FK Human interleukin-7 R&D systems Cat#206-IL-010 Human stem cell factor R&D systems Cat#255-SC Puromycin Thermo Fisher Cat#A1113803 Neomycin Carl Roth Cat #CP11.2 Blasticidin Thermo Fisher Cat#R21001 Polybrene Merck Millipore Cat#TR-1003-G Lipofectamine 2000 Invitrogen Cat#11668030 Dexamethasone Sigma-Aldrich Cat#D4902 Vincristine Selleckchem Cat#S1241 6-Mercaptopurine Abcam Cat#ab142389 Rapamycin Selleckchem Cat#S1039 BRD5648 (Wagner et al., 2018) N/A BRD0705 (Wagner et al., 2018) N/A BRD3731 (Wagner et al., 2018) N/A HSP70 inhibitors B (Kang et al., 2014; Taldone et al., 2014). .. CD34+ progenitors were cultured in RPMI (Thermo Fisher Scientific) supplemented with 20% FBS and Article Title: Concomitant inhibition of the thioredoxin system and nonhomologous DNA repair potently sensitizes Philadelphia‐positive lymphoid leukemia to tyrosine kinase inhibitors Article Snippet: For frozen samples whose viability after thawing was less than 90%, dead cells were discarded through centrifugation in the Lymphoprep (STEMCELL Technologies) gradient. .. Cells were seeded onto a 96‐well U‐bottom plate at 0.5 × 10 6 cells/mL in a final volume of 200 μL of SFEM II medium (Gibco), supplemented with 20% FBS (Gibco), 20 ng/mL Concentration Assay:Article Title: Supramolecular assembly of GSK3α as a cellular response to amino acid starvation. Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Chemicals, Peptides, and Recombinant Proteins Asparaginase (pegaspargase) Shire Pharmaceuticals Oncaspar Trypan blue Invitrogen Cat#T10282 Human FLT3 R&D systems Cat#398-FK Human interleukin-7 R&D systems Cat#206-IL-010 Human stem cell factor R&D systems Cat#255-SC Puromycin Thermo Fisher Cat#A1113803 Neomycin Carl Roth Cat #CP11.2 Blasticidin Thermo Fisher Cat#R21001 Polybrene Merck Millipore Cat#TR-1003-G Lipofectamine 2000 Invitrogen Cat#11668030 Dexamethasone Sigma-Aldrich Cat#D4902 Vincristine Selleckchem Cat#S1241 6-Mercaptopurine Abcam Cat#ab142389 Rapamycin Selleckchem Cat#S1039 BRD5648 (Wagner et al., 2018) N/A BRD0705 (Wagner et al., 2018) N/A BRD3731 (Wagner et al., 2018) N/A HSP70 inhibitors B (Kang et al., 2014; Taldone et al., 2014). .. CD34+ progenitors were cultured in RPMI (Thermo Fisher Scientific) supplemented with 20% FBS and Article Title: Concomitant inhibition of the thioredoxin system and nonhomologous DNA repair potently sensitizes Philadelphia‐positive lymphoid leukemia to tyrosine kinase inhibitors Article Snippet: For frozen samples whose viability after thawing was less than 90%, dead cells were discarded through centrifugation in the Lymphoprep (STEMCELL Technologies) gradient. .. Cells were seeded onto a 96‐well U‐bottom plate at 0.5 × 10 6 cells/mL in a final volume of 200 μL of SFEM II medium (Gibco), supplemented with 20% FBS (Gibco), 20 ng/mL Centrifugation:Article Title: Preventing Differentiation Towards Primitive Macrophages in Stem Cells With Down Syndrome. Article Snippet: On days 0, 2, and 4 of differentiation, cells were cultured in SF- DIFF medium and further supplemented with the following cytokines and chemicals: day 0: 0.5 mM L- ascorbic acid (Sigma- Aldrich), 0.45 mM monothioglycerol (Fujifilm Wako Chemicals), 5 ng/mL recombinant human bone morphogenic protein- 4 (rhBMP- 4, R&D Systems, Minneapolis, MN, USA), 5 ng/mL recombinant human fibroblast growth factor 2 (rhFGF2, R&D Systems); day 2: 0.5 mM L- ascorbic acid, 0.45 mM monothioglycerol, 2 ng/ mL rhBMP- 4, 5 ng/mL rhFGF2, 5 ng/mL recombinant human vascular endothelial growth factor (rhVEGF, R&D Systems), and 2 ng/mL recombinant human/mouse/rat activin A (rhactivin A, R&D Systems); day 4: 0.5 mM L- ascorbic acid, 0.45 mM monothioglycerol, 25 μg/mL gentamicin (FUJIFILM Wako Pure Chemical Corporation), 5 ng/mL rhVEGF and 100 ng/ mL recombinant human colony stimulating factor 1 (rhCSF- 1, R&D Systems). .. On day 6, the culture medium was switched to StemPro- 34 medium (Thermo Fisher Scientific) containing 0.5 mM L- ascorbic acid, 0.45 mM monothioglycerol, penicillin–streptomycin (1×), 150 μg/mL transferrin from human serum (Roche, Basel, Switzerland), 2.0 mM glutamine, 50 ng/ mL rhCSF- 1, 100 ng/mL recombinant human stem cell factor (rhSCF, Nacalai Tesque), 10 ng/mL Article Title: Preventing Differentiation Towards Primitive Macrophages in Stem Cells With Down Syndrome Article Snippet: On days 0, 2, and 4 of differentiation, cells were cultured in SF‐DIFF medium and further supplemented with the following cytokines and chemicals: day 0: 0.5 mM L‐ascorbic acid (Sigma‐Aldrich), 0.45 mM monothioglycerol (Fujifilm Wako Chemicals), 5 ng/mL recombinant human bone morphogenic protein‐4 (rhBMP‐4, R&D Systems, Minneapolis, MN, USA), 5 ng/mL recombinant human fibroblast growth factor 2 (rhFGF2, R&D Systems); day 2: 0.5 mM L‐ascorbic acid, 0.45 mM monothioglycerol, 2 ng/mL rhBMP‐4, 5 ng/mL rhFGF2, 5 ng/mL recombinant human vascular endothelial growth factor (rhVEGF, R&D Systems), and 2 ng/mL recombinant human/mouse/rat activin A (rhactivin A, R&D Systems); day 4: 0.5 mM L‐ascorbic acid, 0.45 mM monothioglycerol, 25 μg/mL gentamicin (FUJIFILM Wako Pure Chemical Corporation), 5 ng/mL rhVEGF and 100 ng/mL recombinant human colony stimulating factor 1 (rhCSF‐1, R&D Systems). .. On day 6, the culture medium was switched to StemPro‐34 medium (Thermo Fisher Scientific) containing 0.5 mM L‐ascorbic acid, 0.45 mM monothioglycerol, penicillin–streptomycin (1×), 150 μg/mL transferrin from human serum (Roche, Basel, Switzerland), 2.0 mM glutamine, 50 ng/mL rhCSF‐1, 100 ng/mL recombinant human stem cell factor (rhSCF, Nacalai Tesque), 10 ng/mL other:Article Title: Disruption of the tumour-associated EMP3 enhances erythroid proliferation and causes the MAM-negative phenotype Article Snippet: The annealed guide DNA oligonucleotides were then diluted 1:100 in cold 1× Tris-EDTA buffer (Sigma-Aldrich). Flow Cytometry:Article Title: Concomitant inhibition of the thioredoxin system and nonhomologous DNA repair potently sensitizes Philadelphia‐positive lymphoid leukemia to tyrosine kinase inhibitors Article Snippet: For frozen samples whose viability after thawing was less than 90%, dead cells were discarded through centrifugation in the Lymphoprep (STEMCELL Technologies) gradient. .. Cells were seeded onto a 96‐well U‐bottom plate at 0.5 × 10 6 cells/mL in a final volume of 200 μL of SFEM II medium (Gibco), supplemented with 20% FBS (Gibco), 20 ng/mL Staining:Article Title: Concomitant inhibition of the thioredoxin system and nonhomologous DNA repair potently sensitizes Philadelphia‐positive lymphoid leukemia to tyrosine kinase inhibitors Article Snippet: For frozen samples whose viability after thawing was less than 90%, dead cells were discarded through centrifugation in the Lymphoprep (STEMCELL Technologies) gradient. .. Cells were seeded onto a 96‐well U‐bottom plate at 0.5 × 10 6 cells/mL in a final volume of 200 μL of SFEM II medium (Gibco), supplemented with 20% FBS (Gibco), 20 ng/mL |